Contract Research Organization (CRO) Market Outlook, Current Strategies and Growth by Top Companies: Medpace, PRA Health Sciences, Clinipace

Contract Research Organization (CRO), also sometimes referred as also referred as clinical research organization are key constituent of the drug development process, offers range of services to pharmaceutical and biopharmaceutical companies. CRO's can provide services such as early phase development services (includes discovery studies, chemistry, manufacturing & control), Pharmacokinetics/Pharmacodynamics (PK/PD), toxicology testing, clinic research services (Phase I, Phase II, Phase III, Phase IV), laboratory services, analytical and bioanalytical testing, physical characterization, and consulting services. CRO also extend their services to governmental institutes, Universities, in addition to research institutions. CRO's help in the drug development various major diseases such as oncology, cardiovascular disease, diabetes, infectious diseases, CNS disorders, respiratory disorders and other disorders.

Major Key Players of the Contract Research Organization (CRO) Market are:
Charles River Laboratories International (CRL), Medpace, PRA Health Sciences, Clinipace, ICON, CMIC, LabCorp (Covance), Parexel International Corporation, Laboratory Corporation of America Holdings, PPD, EPS International, IQVIA (Quintiles IMS), RxCelerate, Optimapharm, Syneos Health

Comments

Popular posts from this blog

Southeast Asia and Middle East Copper Wire and Cable Market: A Brief Evaluation of the Industry’s Prospects from 2023 to 2032

The Global Beacon Market: Exploring Its Emerging Trends and Investment Opportunities (2024-2032)

RFID Tags Market to Witness an Outstanding Growth during 2019-2026 – Honeywell, NXP Semiconductors, Alien Technology